AU6473699A - Aqueous drug formulation for oral application - Google Patents

Aqueous drug formulation for oral application

Info

Publication number
AU6473699A
AU6473699A AU64736/99A AU6473699A AU6473699A AU 6473699 A AU6473699 A AU 6473699A AU 64736/99 A AU64736/99 A AU 64736/99A AU 6473699 A AU6473699 A AU 6473699A AU 6473699 A AU6473699 A AU 6473699A
Authority
AU
Australia
Prior art keywords
drug formulation
oral application
aqueous drug
aqueous
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64736/99A
Other languages
English (en)
Inventor
Tobias Laich
Hans-Martin Siefert
Annette Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU6473699A publication Critical patent/AU6473699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU64736/99A 1998-10-30 1999-10-19 Aqueous drug formulation for oral application Abandoned AU6473699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19850069 1998-10-30
DE19850069 1998-10-30
PCT/EP1999/007891 WO2000025765A2 (de) 1998-10-30 1999-10-19 Wässrige arzneimittelformulierung zur oralen applikation

Publications (1)

Publication Number Publication Date
AU6473699A true AU6473699A (en) 2000-05-22

Family

ID=7886163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64736/99A Abandoned AU6473699A (en) 1998-10-30 1999-10-19 Aqueous drug formulation for oral application

Country Status (3)

Country Link
AU (1) AU6473699A (de)
HN (1) HN1999000174A (de)
WO (1) WO2000025765A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
MX2011012134A (es) 2009-05-15 2012-02-08 Redx Pharma Ltd Derivados de farmaco de oxido-reduccion.
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form

Also Published As

Publication number Publication date
WO2000025765A3 (de) 2000-08-03
WO2000025765A2 (de) 2000-05-11
HN1999000174A (es) 1999-10-13

Similar Documents

Publication Publication Date Title
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
HK1041224A1 (zh) 新的藥物製劑
AU1071301A (en) Pharmaceutical compounds
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU4328800A (en) Pharmaceutical formulation
AU1887401A (en) Medicinal composition
AU2177001A (en) Use of indirubine derivatives for making medicines
AU6715600A (en) Pharmaceutical formulations
AU2564399A (en) Isoflavanoid formulations for oral administration
AU4977300A (en) Pharmaceutical formulations
AU1732401A (en) Medicinal compositions for oral use
AU1385801A (en) Pharmaceutical formulations
AU5722900A (en) Pharmaceutical compounds
GB9818927D0 (en) Pharmaceutical formulation
AU5378599A (en) Oral formulation
AU1688099A (en) Pharmaceutical preparation
AU5415699A (en) Water-soluble pharmaceutical formulation for administering sildenafil
AU6473699A (en) Aqueous drug formulation for oral application
AU3839900A (en) Pharmaceutical formulation
AU2870899A (en) Oral formulation for hydrophilic drugs
AU5182099A (en) Pharmaceutical formulation
AU1304601A (en) Solid preparations for oral use
GB9822333D0 (en) Pharmaceutical formulation
AU1388501A (en) Pharmaceutical formulation
AU2156800A (en) Oral antiestrogen pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase